Myopathy with anti-Jo-1 antibodies: Pathology in perimysium and neighbouring muscle fibres

Journal of Neurology Neurosurgery and Psychiatry

Volumn 68, Issue 4, 2000, Pages 472-478

  Mozaffar, Tahseen ^a   Pestronk, Alan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fasciitis; Immune; Jo 1 antibody; Myopathy; Myositis

Indexed keywords

HISTIDINE TRANSFER RNA LIGASE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CAPILLARY DENSITY; CLINICAL ARTICLE; CONNECTIVE TISSUE; FEMALE; HUMAN; MACROPHAGE ACTIVATION; MALE; MUSCLE ATROPHY; MUSCLE CELL; MYOPATHY; MYOSITIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AUTOANTIBODIES; FEMALE; HISTIDINE-TRNA LIGASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCULAR DISEASES;

EID: 0034057944     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.68.4.472     Document Type: Article

References (32)

1. Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol 1990;144:1737-43.
2. von Muhlen C, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24:323-58.
3. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983;304:177-9.
4. Arnett FC, Hirsch TJ, Bias WB, et al. The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J Rheumatol 1981;8:925-30.
5. Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996;26:459-67.
6. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
7. Bohan A, Peter JB, Bowman RL, et al. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977;56:255-86.
8. Blume G, Pestronk A, Frank B, et al. Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain 1997;120:39-45.
9. Dubowitz. Muscle biopsy, a practical approach. London: Ballière Tindall, 1985:19-40.
10. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies: IV. Cell-mediated toxicity and muscle fiber necrosis. Ann Neurol 1988;23: 168-73.
11. Emslie-Smith A, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990;27:343-56.
12. Targoff IN, Reichlin M. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol 1987;138:2874-82.
13. Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 1980;23:881-8.
14. Yoshida S, Akizuki M, Mimori T, et al. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983;26:604-11.
15. Yang DC, Dang CV, Arnett FC. Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody. Biochem Biophys Res Commun 1984;120:15-21.
16. Shi MH, Tsui FW, Rubin LA. Cellular localization of the target structures recognized by the anti-Jo-1 antibody: immunofluorescence studies on cultured human myoblasts. J Rheumatol 1991;18:252-8.
17. Bernstein RM, Morgan SH, Chapman J, et al. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. BMJ 1984;289:151-2.
18. Cohen MG, Ho KK, Webb J. Finger joint calcinosis followed by osteolysis in a patient with multisystem connective tissue disease and anti-Jo-1 antibody. J Rheumatol 1987;14:605-8.
19. Oddis CV, Medsger TAJ, Cooperstein LA. A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis. Arthritis Rheum 1990;33: 1640-5.
20. Mitra D, Lovell CL, Macleod TI, et al. Clinical and histological features of mechanic's hands in a patient with antibodies to Jo-1-a case report. Clin Exp Dermatol 1994;19:146-8.
21. Targoff IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994;20:857-80.
22. Rider LG, Miller FW, Targoff IN, et al. A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis Rheum 1994;37:1534-8.
23. al-Janadi M, Smith CD, Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/ dermatomyositis. J Rheumatol 1989;16:1592-6.
24. Jenkins EA, Hull RG, Thomas AL. D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody. Br J Rheumatol 1993;32:1109-10.
25. Dawson JK, Abernethy VE, Lynch MP. Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporin. Br J Rheumatol 1997;36:144-5.
26. Engel AG, Arahata K, Emslie-Smith A. Immune effector mechanisms in inflammatory myopathies. Res Publ Assoc Res Nerv Ment Dis 1990;68:141-57.
27. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325:1487-98.
28. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986;314:329-34.
29. Ringel SP, Carry MR, Aguilera AJ, Starcevich JM. Quantitative histopathology of the inflammatory myopathies. Arch Neurol 1986;43:1004-9.
30. Ringel SP, Forstot JZ, Tan EM, et al. Sjögren's syndrome and polymyositis or dermatomyositis. Arch Neurol 1982;39: 157-63.
31. Simon DB, Ringel SP, Sufit RL. Clinical spectrum of fascial inflammation. Muscle Nerve 1982;5:525-37.
32. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360-74.